• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

作者信息

Heidenreich Paul A, Estes N A Mark, Fonarow Gregg C, Jurgens Corrine Y, Kittleson Michelle M, Marine Joseph E, McManus David D, McNamara Robert L

机构信息

ACC/AHA Task Force on Performance Measures Liaison.

Heart Rhythm Society Representative.

出版信息

Circ Cardiovasc Qual Outcomes. 2021 Jan;14(1):e000100. doi: 10.1161/HCQ.0000000000000100. Epub 2020 Dec 7.

DOI:10.1161/HCQ.0000000000000100
PMID:33284642
Abstract
摘要

相似文献

1
2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.《2016年美国心脏病学会/美国心脏协会心房颤动或心房扑动成年患者临床操作与质量指标2020年更新：美国心脏病学会/美国心脏协会性能指标工作组报告》
Circ Cardiovasc Qual Outcomes. 2021 Jan;14(1):e000100. doi: 10.1161/HCQ.0000000000000100. Epub 2020 Dec 7.
2
2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.2016年美国心脏病学会/美国心脏协会房颤或房扑成年患者临床操作与质量指标：美国心脏病学会/美国心脏协会性能指标工作组报告
Circ Cardiovasc Qual Outcomes. 2016 Jul;9(4):443-88. doi: 10.1161/HCQ.0000000000000018. Epub 2016 Jun 27.
3
ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society.美国心脏病学会/美国心脏协会/医师协会2008年非瓣膜性心房颤动或心房扑动成人患者临床性能指标：美国心脏病学会/美国心脏协会性能指标特别工作组及性能改进医师协会（心房颤动临床性能指标制定写作委员会）报告：与心律学会合作制定
Circulation. 2008 Feb 26;117(8):1101-20. doi: 10.1161/CIRCULATIONAHA.107.187192. Epub 2008 Feb 18.
4
2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.2016年美国心脏病学会/美国心脏协会房颤或房扑成年患者临床诊疗表现及质量指标：美国心脏病学会/美国心脏协会性能指标特别工作组报告
J Am Coll Cardiol. 2016 Aug 2;68(5):525-568. doi: 10.1016/j.jacc.2016.03.521. Epub 2016 Jun 27.
5
2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.2016年美国心脏病学会/美国心脏协会房颤或心房扑动成年患者临床性能和质量指标2020年更新：美国心脏病学会/美国心脏协会性能指标工作组报告
J Am Coll Cardiol. 2021 Jan 26;77(3):326-341. doi: 10.1016/j.jacc.2020.08.037. Epub 2020 Dec 7.
6
ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults with Nonvalvular Atrial Fibrillation or Atrial Flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation) Developed in Collaboration with the Heart Rhythm Society.美国心脏病学会/美国心脏协会/医师协会2008年非瓣膜性心房颤动或心房扑动成人临床性能指标：美国心脏病学会/美国心脏协会性能指标特别工作组和医师协会性能改善委员会（制定心房颤动临床性能指标写作委员会）与心律协会合作制定的报告。
J Am Coll Cardiol. 2008 Feb 26;51(8):865-84. doi: 10.1016/j.jacc.2008.01.006.
7
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.2019年美国心脏协会/美国心脏病学会/心律学会对2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南的聚焦更新：美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会与胸外科医师协会合作报告
Circulation. 2019 Jul 9;140(2):e125-e151. doi: 10.1161/CIR.0000000000000665. Epub 2019 Jan 28.
8
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南：心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30.
9
2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2019年美国心脏协会/美国心脏病学会/心律学会对2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南的重点更新：美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会的报告
Heart Rhythm. 2019 Aug;16(8):e66-e93. doi: 10.1016/j.hrthm.2019.01.024. Epub 2019 Jan 28.
10
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南：心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.

引用本文的文献

1
Consequences of the Poor Anticoagulation Control of Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonists.维生素K拮抗剂治疗的非瓣膜性心房颤动患者抗凝控制不佳的后果。
J Clin Med. 2024 Oct 30;13(21):6495. doi: 10.3390/jcm13216495.
2
Influence of the COVID-19 pandemic on patients receiving oral anticoagulants for the treatment of non-valvular atrial fibrillation.2019年冠状病毒病大流行对接受口服抗凝剂治疗非瓣膜性心房颤动患者的影响。
Int J Cardiol Heart Vasc. 2024 Feb 10;51:101358. doi: 10.1016/j.ijcha.2024.101358. eCollection 2024 Apr.
3
Exercise-induced atrial fibrillation: A case report.
运动诱发的心房颤动：一例报告。
Clin Case Rep. 2023 Nov 20;11(11):e8242. doi: 10.1002/ccr3.8242. eCollection 2023 Nov.
4
Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol.西班牙非瓣膜性心房颤动相关的医疗资源和成本：阿哌沙班与华法林。
J Comp Eff Res. 2023 Aug;12(8):e230007. doi: 10.57264/cer-2023-0007. Epub 2023 Jul 25.
5
Management of Stroke in Patients With Chronic Liver Disease: A Practical Review.慢性肝脏疾病患者脑卒中的管理：实用综述。
Stroke. 2023 Sep;54(9):2461-2471. doi: 10.1161/STROKEAHA.123.043011. Epub 2023 Jul 7.
6
[Serum levels of endothelin-1 and connective tissue growth factor are elevated in patients with atrial fibrillation and correlated with relapse following radiofrequency ablation].心房颤动患者血清内皮素-1和结缔组织生长因子水平升高，并与射频消融术后复发相关
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Nov 20;42(11):1689-1696. doi: 10.12122/j.issn.1673-4254.2022.11.13.
7
Medical therapy for patients with recent-onset heart failure with reduced ejection fraction during the COVID-19 pandemic: Insights from the Veteran's affairs healthcare system.COVID-19大流行期间射血分数降低的近期发病心力衰竭患者的药物治疗：来自退伍军人事务医疗系统的见解
Am Heart J Plus. 2022 Oct;22:100210. doi: 10.1016/j.ahjo.2022.100210. Epub 2022 Sep 17.
8
DOACs in Mechanical and Bioprosthetic Heart Valves: A Narrative Review of Emerging Data and Future Directions.口服抗凝药物在机械瓣和生物瓣中的应用：新兴数据与未来方向的叙述性综述。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221103578. doi: 10.1177/10760296221103578.
9
Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines - Atrial Fibrillation (GWTG-AFIB) registry.在因心房颤动住院的患者中取得的成就和质量衡量标准：来自“遵循指南-心房颤动（GWTG-AFIB）登记”的结果。
Am Heart J. 2022 Mar;245:90-99. doi: 10.1016/j.ahj.2021.12.002. Epub 2021 Dec 18.